Lynne Braidwood, Kirsty Learmonth, Alex Graham, Joe Conner Virttu Biologics Ltd, Department of Neurology, Southern General Hospital, Glasgow, UK Abstract: Oncolytic herpes simplex virus (HSV1716), lacking the neurovirulence factor ICP34.5, has highly ...
Braidwood L +3 more
core
The role and mechanism of neutrophils in oncolytic virus therapy. [PDF]
Huang B, Yang Q, Wang R, Zhao C.
europepmc +1 more source
Development of an oncolytic agent based on the Herpes Simplex Virus type 1 expressing the KillerRed protein targeted to the plasma membrane. [PDF]
openLa viroterapia oncologica rappresenta un promettente approccio per la cura di tumori e neoplasie solide, specialmente per quelli caratterizzati da prognosi infausta e limitata efficacia degli approcci terapeutici classici (resezione chirurgica ...
FEMMINELLA, MADDALENA
core
Oncolytic viruses: Revolutionising the fight against tumours
Zeda Zhao, Yinan Shen, Tingbo Liang
doaj +1 more source
Oncolytic Virus-Engineered Extracellular Vesicles Rewire Glioblastoma Immunity. [PDF]
Kiel K +18 more
europepmc +1 more source
Apoptotic Macrophage-Derived Vesicles Loaded with Oncolytic Virus for Tumor Therapy. [PDF]
Wang Z, Yan Z, Tan M, Deng J, Wang J.
europepmc +1 more source
Oncolytic virus with an immune stimulatory payload for osteosarcoma therapy. [PDF]
Khan S +9 more
europepmc +1 more source
Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. [PDF]
Zhang M +17 more
europepmc +1 more source
Oncolytic virus-mediated GPC3 delivery overcomes antigen heterogeneity in hepatocellular carcinoma and enhances GPC3-directed immunotherapy. [PDF]
Chaurasiya S +15 more
europepmc +1 more source

